Results 11 to 20 of about 1,258 (160)

Tumefactive Demyelinating Lesion Induced by Infliximab in a Patient With Rheumatoid Arthritis: A Case Report [PDF]

Clinical Case Reports
Tumor Necrosis Factor‐alpha (TNF‐α) inhibitors have been successfully used to treat rheumatoid arthritis (RA), psoriatic and ankylosing arthritis, and inflammatory bowel disease.
Shahla Mohammed Saeed Rasul, Zana Abdulrahman Mohammed, Aran Asaad Adiban, Yahya Jawad Kadhm   +3 more
doaj   +3 more sources

Idiopathic Intracranial Hypertension Preceding Tumefactive Multiple Sclerosis. [PDF]

Cureus
Idiopathic intracranial hypertension (IIH) and multiple sclerosis (MS) are rare neurological disorders that largely affect females within the reproductive age group. The clinical pictures of both diseases can overlap, which therefore places great importance on accurately studying and reporting their concurrence.
Alrashidi TJ, Nasif EM, Alshurem M.
europepmc   +3 more sources

Tumefactive multiple sclerosis presenting with tonic-clonic seizure. [PDF]

BMJ Case Rep, 2016
A 37-year-old Hispanic man with no medical history presented with sudden onset of two episodes of witnessed seizure. On arrival to the emergency room, he experienced another episode of generalised tonic–clonic seizure witnessed by the physician and nurses.
Idris AA, Begum T, Verlage KR, Ahmed M.
europepmc   +4 more sources

Tumefactive demyelinating lesions: a case report and literature review [PDF]

BMC Neurology
Tumefactive multiple sclerosis (TMS) is a rare and diagnostically challenging variant of demyelinating disease that frequently mimics neoplastic, infectious, or vascular brain lesions.
Raneem Jaki, Zyad Al-Frejat, Ziad Bitar
doaj   +2 more sources

Fingolimod‐associated Balo's concentric sclerosis in multiple sclerosis: A case report

Clinical Case Reports
Key Clinical Message A report of Balo's concentric sclerosis developed alongside with fingolimod use in a patient with previously diagnosed multiple sclerosis.
Parisa Sharifi, Amir Moradi, Abdorreza Naser Moghadasi   +2 more
doaj   +2 more sources

Role of Therapeutic Plasma Exchange in Treatment of Tumefactive Multiple Sclerosis-Associated Low CD4 and CD8 Levels [PDF]

Case Reports in Neurology, 2016
We report a 35-year-old healthy male who developed central nervous system inflammatory demyelinating disease consistent with tumefactive multiple sclerosis.
Kristen Lew, Nishith Mewada, Sahana Ramanujam, Bahareh Hassanzadeh, John E. Donahue, Leema Reddy Peddareddygari, Robert Moser, Charles  Kososky, Raji P. Grewal   +8 more
doaj   +2 more sources

Decisive role of brain biopsy in atypical tumefactive demyelinating lesions: A case report [PDF]

Radiology Case Reports
In neuroimaging, tumefactive demyelinating lesions (TDLs), which are rare inflammatory lesions of the central nervous system, can sometimes resemble infectious or malignant processes. Radiologic distinction is frequently made more difficult by their huge
Nazlı Gamze Bülbül, MD, Asel Jusupova, MD, Buse Gül Belen, MD, Başak Ceren Okcu Korkmaz, MD, Fatma Sibel Bayramoğlu, MD, Mehmet Fatih Özdağ, MD, Rıfat Erdem Toğrol, MD, Aydın Sav, MD, Aksel Siva, MD   +8 more
doaj   +2 more sources

Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment [PDF]

Therapeutic Advances in Neurological Disorders, 2015
Background: Fingolimod (FTY) is the first oral medication approved for multiple sclerosis therapy. Until now, little has been known about the effects of FTY withdrawal regarding disease activity and development of tumefactive demyelinating lesions (TDLs),
Simon Faissner, Robert Hoepner, Carsten Lukas, Andrew Chan, Ralf Gold, Gisa Ellrichmann   +5 more
doaj   +2 more sources

A case of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations [PDF]

Radiology Case Reports
Retinal vasculopathy with cerebral leukoencephalopathy (RVCL) is an autosomal dominant disorder caused by mutations in the TREX1 gene, which affects medium and small arteries and veins. Reported in fewer than 50 families worldwide, RVCL typically affects
Musharaf Khan, DO, Subtain Ali, MD, Bushra Sayeed, MD, Eyassu Hailemichael, MD, Dhairya A. Lakhani, MD   +4 more
doaj   +2 more sources

TUMEFACTIVE MULTIPLE SCLEROSIS: A DIAGNOSTIC ENIGMA. A CASE REPORT [PDF]

Journal of IMAB, 2023
Purpose: To present a clinical case of tumefactive multiple sclerosis (TMS), which is an inflammatory demyelinating disease of the central nervous system considered to be a rare form of multiple sclerosis (MS). It belongs to the group of borderline forms
Magdalina Yanakieva, Maya Danovska, Emilia Ovcharova, Diana Marinova, Nicholas Shepherd   +4 more
doaj   +1 more source